Neurocrine Biosciences (NBIX) Market Cap 1996–2026

As of November 13, 2026, Neurocrine Biosciences had a market cap of $16.96 billion, which decreased by 1.17% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Nov 13, 2026, 4:00 PM ET
Neurocrine Biosciences logo

Neurocrine Biosciences Inc. (NBIX)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$16.96B ▼ 1.17%
Start of 2026
$14.14B ▲ 19.94%
1 Year Ago
$14.37B ▲ 18.02%
All-Time High
$18.66B ▼ 9.11%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Neurocrine Biosciences Market Cap History by Year and Month

Neurocrine Biosciences Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$16.96B▲ 19.94%
$16.96B▲ 14.29%
$14.84B▲ 2.98%
$14.41B▼ 7.92%
$15.65B▼ 6.73%
$16.78B▼ 1.00%
$16.95B▲ 6.47%
$15.92B▲ 20.51%
$13.21B▼ 0.08%
$13.22B▼ 0.38%
$13.27B▼ 2.21%
$13.57B▼ 4.03%
2025$14.14B▲ 4.22%
2024$13.568B▲ 4.81%
2023$12.945B▲ 12.75%
2022$11.482B▲ 42.05%
All market cap values reflect closing prices for the period shown.

📊 Neurocrine Biosciences Market Cap and Other Industry Peers

Below are selected companies for comparison based on industry, sub-industry, and sector:

  1. $26.57B
  2. $25.06B
  3. $24.68B
  4. $22.09B
  5. $16.96B
  6. $16.88B
  7. $15.35B
  8. $11.42B
  9. $11.32B
  10. $11.08B
  11. $10.88B
  12. $9.93B
  13. $9.46B
  14. $9.17B
  15. $9.04B
  16. $8.54B
  17. $7.97B
  18. $7.81B
  19. $6.74B
  20. $6.61B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.